| ABBVIE INC. DL-,01 |
| USA |
| Gesundheit |
| US00287Y1091 / A1J84E |
| 4AB (Frankfurt) / ABBV (NYSE) |
| FRA:4AB, ETR:4AB, 4AB:GR, NYSE:ABBV |
| S&P500 |
| https://www.abbvie.com/ |
|
AbbVie Inc. is a prominent biopharmaceutical compa..
>Volltext.. |
| 343633.32 Mio. EUR |
| 398145.03 Mio. EUR |
| 50395.5 Mio. EUR |
| 23112.05 Mio. EUR |
| 3216.68 Mio. EUR |
| 1.82 EUR |
| 60895.71 Mio. EUR |
| 5587.5 Mio. EUR |
| 16660.55 Mio. EUR |
| 0.16 |
| -3.57% |
| -36.09% |
| 5.63 EUR |
| 2.87% |
| 2.91% |
| 15.10.25 - 1.40712€ 15.07.25 - 1.40712€ >weitere anzeigen... |
| - |
| ABBVIE |
| 31.10.25 |
|
||||
|
||||
|